A German court ruled in favor of patients suffering from vaccine side effects, easing access to information from pharmaceutical companies regarding potential risks.
In a significant ruling by the Federal Court of Germany (Bundesgerichtshof - BGH), the court has revised its previous stance regarding the information rights of patients suffering from adverse effects from the AstraZeneca COVID-19 vaccine. This decision is particularly impactful for a plaintiff who claimed damages due to health issues allegedly caused by the vaccine. The BGH's ruling allows for more straightforward legal channels for injured patients to obtain information from pharmaceutical manufacturers about their products, which is essential for pursuing liability claims.
